Fortitude Group, Inc. (FRTD) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerFortitude Group, Inc. (FRTD) trades at $0.00002. Fortitude Group Inc. focuses on developing solutions for the medical community through its portfolio of medical devices and advanced technology. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for FRTD: FRTD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Fortitude Group, Inc. (FRTD) Financial Services Profile
Fortitude Group Inc. operates within the financial services sector, focusing on asset management and developing solutions for the medical community. The company's portfolio includes medical devices and advanced technology, aiming to improve patient outcomes and prevent risks. It faces competition from established asset management firms and medical technology companies.
What Is the Investment Thesis for FRTD?
Investing in Fortitude Group Inc. presents a speculative opportunity given its focus on the medical device and technology sector. Key value drivers include the successful development and commercialization of its product portfolio, which aims to improve patient outcomes and prevent risks. Growth catalysts involve expanding its market reach through strategic partnerships and acquisitions. However, potential investors may want to evaluate the risks associated with the company's OTC market listing, limited financial disclosure, and high beta of 8.68, indicating significant volatility. The company's ability to secure funding for research and development and navigate regulatory hurdles will be critical for its long-term success.
Based on FMP financials and quantitative analysis
FRTD Key Highlights
Fortitude Group Inc. focuses on developing solutions for the medical community, including medical devices and advanced technology.
- The company aims to improve patient outcomes by preventing risks through its products and procedures.
- Fortitude Group operates through direct holdings, subsidiaries, and joint ventures.
- The company was formerly known as Rounder, Inc., changing its name to Fortitude Group, Inc. in January 2013.
- The company's beta is 8.68, indicating high volatility compared to the market.
Who Are FRTD's Competitors?
FRTD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CHYL Unified Global Corp. | $0.46 | +0.00% | $27.1M | — |
| BTTC Black Titan Corporation | $0.65 | +2.57% | $5.02M | 53 5-pillar |
| FOFO Hang Feng Technology Innovation Co., Ltd. | $2.09 | -0.95% | $15.8M | 79 5-pillar |
| BCG Binah Capital Group, Inc. | $1.01 | -9.71% | $17.0M | 78 5-pillar |
| PDPA Pearl Diver Credit Company Inc. | $24.96 | +0.65% | $59.0M | 52 5-pillar |
| SSEA Starry Sea Acquisition Corp | $10.37 | -0.19% | $79.2M | 55 5-pillar |
| SAMG Silvercrest Asset Management Group Inc. | $10.54 | +0.48% | $81.0M | 51 5-pillar |
| HNNA Hennessy Advisors, Inc. | $10.31 | -0.77% | $81.5M | 85 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FRTD's Key Strengths?
Focus on medical device and technology solutions
- Potential for improving patient outcomes
- Operates through diverse holdings and ventures
- Commitment to preventing risks in healthcare
What Are FRTD's Weaknesses?
OTC market listing indicates higher risk
- Limited financial disclosure
- High beta suggests significant volatility
- Dependence on successful product development
What Are the Key Risks for FRTD?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory hurdles and compliance costs.
- Competition from established medical device companies.
- Technological obsolescence.
- Economic downturn affecting healthcare spending.
- Risks associated with OTC market listing and limited financial disclosure.
What Are FRTD's Competitive Advantages?
- Proprietary medical device technology
- Strategic partnerships with healthcare providers
- Focus on patient-centric solutions
What Does FRTD Do?
Fortitude Group Inc., headquartered in Erie, Pennsylvania, is dedicated to developing solutions for the medical community. The company, through its direct holdings, subsidiaries, and joint ventures, focuses on utilizing a product portfolio that includes medical devices, advanced technology, and medical protocol procedures. These are engineered to prevent risk and improve patient outcomes. Founded with the goal of addressing critical needs within the healthcare sector, Fortitude Group has evolved from its origins as Rounder, Inc., officially changing its name in January 2013 to reflect its new strategic direction. The company's current market position involves leveraging its diverse portfolio to offer integrated solutions that enhance patient care and safety. By combining medical devices with advanced technological applications, Fortitude Group aims to provide comprehensive solutions that address the evolving challenges in healthcare. Its geographic reach is primarily within the United States, with potential for expansion as its product portfolio grows. Fortitude Group competes with other companies in the medical device and healthcare technology sectors, striving to differentiate itself through innovation and a focus on patient-centric solutions.
What Products and Services Does FRTD Offer?
- Develops solutions for the medical community.
- Focuses on medical devices and advanced technology.
- Aims to improve patient outcomes.
- Engineers products to prevent risk.
- Operates through direct holdings, subsidiaries, and joint ventures.
- Offers medical protocol procedures.
How Does FRTD Make Money?
- Develops and markets medical devices.
- Creates advanced technology solutions for healthcare.
- Generates revenue through product sales and licensing agreements.
What Industry Does FRTD Operate In?
Fortitude Group Inc. operates within the asset management industry, focusing on the medical device and healthcare technology sectors. The industry is characterized by rapid innovation, increasing regulatory scrutiny, and a growing demand for patient-centric solutions. The competitive landscape includes established medical device manufacturers, technology companies, and specialized healthcare providers. Fortitude Group aims to differentiate itself through its integrated approach, combining medical devices with advanced technology to improve patient outcomes. The company's success will depend on its ability to navigate the evolving market dynamics and capitalize on emerging opportunities in the healthcare sector.
Who Are FRTD's Key Customers?
- Hospitals and medical centers
- Healthcare providers
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Fortitude Group, Inc. operates in the Asset Management industry within the Financial Services sector. It is headquartered in Erie, US. The company is led by CEO Thomas J. Parilla. FRTD has traded publicly since 2002.
Key Financial Metrics
Return on assets is -35.7%, showing how much profit it generates from its asset base. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Fortitude Group, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
FRTD Financials
FRTD Latest News
-
Stocks That Hit 52-Week Highs On Wednesday
· Dec 18, 2019
FRTD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FRTD.
Price Targets
Wall Street price target analysis for FRTD.
FRTD MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FRTD; grades run from A+ (80-100) to F (below 30).
Leadership: Thomas J. Parilla
CEO
Thomas J. Parilla serves as the Chief Executive Officer of Fortitude Group Inc. His background includes experience in corporate management and strategic development. Parilla has been involved in guiding the company's transition and growth initiatives, focusing on expanding its presence in the medical solutions market. His leadership is centered on driving innovation and improving patient outcomes through the company's product portfolio.
Track Record: Under Thomas J. Parilla's leadership, Fortitude Group Inc. has focused on developing and marketing medical devices and advanced technology solutions. Key milestones include the company's name change in 2013 and its subsequent efforts to establish a presence in the healthcare sector. Parilla's strategic decisions have centered on expanding the company's product portfolio and forming partnerships to enhance its market reach. Specific financial achievements and performance metrics under his tenure are not available.
FRTD OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Fortitude Group Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in these companies.
- OTC Tier: OTC Other
- Limited financial disclosure
- Low trading volume and liquidity
- Potential for price manipulation
- Lack of regulatory oversight
- Higher risk of fraud or bankruptcy
- Verify the availability and accuracy of financial reports.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Review the company's legal and regulatory compliance.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor.
- Consider the potential for dilution through future stock offerings.
- Company's focus on medical solutions
- Efforts to improve patient outcomes
- Existence of direct holdings, subsidiaries, and joint ventures
Common Questions About FRTD (Financials)
What do analysts say about FRTD stock?
As of 2026-03-17, formal analyst coverage of Fortitude Group Inc. (FRTD) is limited due to its OTC listing and smaller market capitalization. Key valuation metrics such as P/E ratio (-0.00) and dividend yield (None) reflect the company's current financial status.
What are the main risks for FRTD?
The main risks for Fortitude Group Inc. include its OTC market listing, which entails limited financial disclosure and regulatory oversight.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data available for Fortitude Group Inc. due to its OTC market listing.